LOGICAL THERAPEUTICS INC

Profile

Company Names

LOGICAL THERAPEUTICS INC

Addresses

300 SECOND AVENUE, WALTHAM, MA 02451

Phone Numbers

781-290-0900

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2005

State Incorporated:

DELAWARE

Total Amount Raised:

$42,537,580.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2010-05-14 
$10,000,000.00 
$16,900,005.00 
$6,900,005.00 
Equity 
1
2007-06-11 
$32,537,580.00 
$32,537,580.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARTIN 
 
EDWARDS 
DIRECTOR
LOGICAL THERAPEUTICS INC   |  TARSA THERAPEUTICS, INC.   |  COLUCID PHARMACEUTICALS, INC.   |  HARMONY BIOSCIENCES II, INC.   |  STARGAZER PHARMACEUTICALS, INC.   |  INOZYME PHARMA, INC.   |  VERONA PHARMA PLC   |  MORPHIC HOLDING, INC.
BRYANT 
 
FONG 
DIRECTOR
NEOS THERAPEUTICS, INC.   |  ODYSSEY THERA INC.   |  LOGICAL THERAPEUTICS INC   |  ALIVEUSA, INC.   |  ACUSPHERE INC   |  WAVETEC VISION SYSTEMS INC   |  STONEPINE CAPITAL, L.P.
LUTZ 
 
GIEBEL 
DIRECTOR
LUX BIOSCIENCES INC   |  LOGICAL THERAPEUTICS INC   |  ALLOCURE INC   |  SV LIFE SCIENCES FUND V LP   |  SV LIFE SCIENCES FUND V STRATEGIC PARTNERS, L.P.   |  PANOPTICA, INC.   |  GOOD START GENETICS, INC.   |  OPHTHOTECH CORP.   |  IPINOVYX BIO, INC.
CAROLYN 
 
GREEN 
EXECUTIVE OFFICER
LOGICAL THERAPEUTICS INC   |  NEXTCURE, INC.   |  ARRAKIS THERAPEUTICS, INC.
PETER 
 
LANKAU 
EXECUTIVE OFFICER, DIRECTOR
LOGICAL THERAPEUTICS INC   |  QUOIN PHARMACEUTICALS, INC.
PAUL 
 
SCHMITT 
DIRECTOR
LOGICAL THERAPEUTICS INC   |  TETRALOGIC PHARMACEUTICALS CORP   |  CERNOSTICS, INC.   |  BELLROCK INTELLIGENCE, INC.   |  PERFORMANCE EFFEM PE FUND, L.P.: SERIES 2017   |  ENVIROLASTECH, INC.   |  PERFORMANCE EFFEM PE FUND, L.P. - SERIES 2018   |  PERFORMANCE EFFEM PE FUND, L.P.: SERIES 2019   |  SURGEONCHECK LLC   |  PERFORMANCE EQUITY GROWTH OPPORTUNITIES FUND, L.P.   |  PERFORMANCE EFFEM PE FUND, L.P.: SERIES 2021   |  PERFORMANCE REGENT 2021 OVERAGE FUND, L.P.   |  PERFORMANCE REGENT 2021 CORE FUND, L.P.   |  PERFORMANCE IOOF CO-INVESTMENT FUND, L.P.   |  PERFORMANCE VENTURE CAPITAL V, L.P.   |  PERFORMANCE EFFEM PE FUND, L.P.: SERIES 2022   |  PERFORMANCE GCP CO-INVESTMENT, L.P.   |  PERFORMANCE VENTURE CAPITAL VI, L.P.   |  PERFORMANCE VENTURE CAPITAL VI FEEDER, L.P.   |  PVC SPECIAL OPPORTUNITIES FUND I, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2010-05-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-14 
2009-08-04
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2007-06-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#